|
1
|
MPM BioImpact
Boston,
Massachusetts
|
$15.9M
|
–
|
–
|
–
|
|
|
2
|
New Leaf Venture Partners
New York
|
$15.7M
|
–
|
–
|
–
|
|
|
3
|
MPM Asset Management
Boston,
Massachusetts
|
$15.6M
|
–
|
–
|
–
|
|
|
4
|
|
$15.1M
|
+$705K
|
+13,600
|
+5%
|
|
|
5
|
|
$8.99M
|
+$494K
|
+9,536
|
+6%
|
|
|
6
|
Franklin Resources
San Mateo,
California
|
$8.27M
|
+$2.34M
|
+45,114
|
+37%
|
|
|
7
|
Vanguard Group
Malvern,
Pennsylvania
|
$6.4M
|
+$178K
|
+3,439
|
+3%
|
|
|
8
|
Point72 Asset Management
Stamford,
Connecticut
|
$5.81M
|
+$2.69M
|
+51,832
|
+80%
|
|
|
9
|
|
$4.97M
|
–
|
–
|
–
|
|
|
10
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$3.94M
|
-$87.5K
|
-1,688
|
-2%
|
|
|
11
|
International Biotechnology Trust
London,
United Kingdom
|
$2.77M
|
-$329K
|
-6,355
|
-30%
|
|
|
12
|
Cormorant Asset Management
Boston,
Massachusetts
|
$2.69M
|
–
|
–
|
–
|
|
|
13
|
Acuta Capital Partners
Redwood City,
California
|
$2.47M
|
+$2.58M
|
+49,750
|
New
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$2.2M
|
+$305K
|
+5,891
|
+15%
|
|
|
15
|
Geode Capital Management
Boston,
Massachusetts
|
$1.97M
|
-$106K
|
-2,038
|
-5%
|
|
|
16
|
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.85M
|
+$235K
|
+4,529
|
+14%
|
|
|
17
|
Tekla Capital Management
Boston,
Massachusetts
|
$1.29M
|
+$1.35M
|
+25,991
|
New
|
|
|
18
|
Schonfeld Strategic Advisors
New York
|
$1.09M
|
+$669K
|
+12,907
|
+144%
|
|
|
19
|
Renaissance Technologies
New York
|
$1.05M
|
+$827K
|
+15,960
|
+309%
|
|
|
20
|
|
$996K
|
-$21.2K
|
-409
|
-2%
|
|
|
21
|
Northern Trust
Chicago,
Illinois
|
$916K
|
-$35.7K
|
-689
|
-4%
|
|
|
22
|
|
$803K
|
+$256K
|
+4,947
|
+44%
|
|
|
23
|
Ikarian Capital
Dallas,
Texas
|
$582K
|
+$29.6K
|
+572
|
+5%
|
|
|
24
|
Kennedy Capital Management
St Louis,
Missouri
|
$558K
|
-$90.3K
|
-1,742
|
-13%
|
|
|
25
|
DAFNA Capital Management
Los Angeles,
California
|
$523K
|
–
|
–
|
–
|
|
